Literature DB >> 7891482

How to assess drug efficacy in osteoporosis.

C Cooper1, J A Kanis, J Compston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7891482     DOI： 10.1016/s0140-6736(95)90635-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?

Authors:  W F Lems; J W Jacobs; J W Bijlsma; G J van Veen; H H Houben; H C Haanen; M I Gerrits; H J van Rijn
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

2.  Calcitonin versus etidronate for the treatment of postmenopausal osteoporosis: a meta-analysis of published clinical trials.

Authors:  J M Cardona; E Pastor
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Should we look for osteoporosis in patients with rheumatoid arthritis?

Authors:  W F Lems; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

4.  Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis.

Authors:  W F Lems; W G Jacobs; J W Bijlsma; A Croone; H C Haanen; H H Houben; M I Gerrits; H J van Rijn
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.